News
The GSC’s response to COVID-19
We all have a responsibility to take precautionary measures in order to help stop the global transmission of COVID-19. The GSC is helping our employees to find ways to attend work safely, including working remotely. We are also moving in-person gatherings to virtual interactions, and all tours of our facilities have been cancelled until further notice. For now, we will continue to accept and sequence samples and maintain all functionality including database and analytical capacities, prioritizing clinical and Personalized OncoGenomics pipelines.

International Women's Day
March 8 was International Women’s Day—a day to celebrate the impact that women and girls have had in the advancement of society, politics, economics and human knowledge. In honour of this day, meet some of the women working here at the GSC.

Finding DNA evidence of bacterial contamination in cancer therapies

Genome sequencing helps prioritize cancer treatment options

A new DNA-based method for tracking samples through the lab

GSC scientists among the most highly cited in the world
Every year, scientists and scholars worldwide publish their findings in academic journals and proceedings, producing papers estimated in the range of more than two million. How does the research community determine the papers with the most value? Citations are one way, and a paper that other scientific authors have frequently cited has arguably proved itself to be highly significant.
Celebrating 20 years of discovery
B.C. Government Honours GSC's 20th Anniversary with a Proclamation
